Bristol-Myers Squibb wins green light from European Medicines Agency to administer Opdivo drug
Bristol-Myers Squibb Company – The approval of Bristol-Myers Squibb's Opdivo has been recommended by European regulators. Opdivo, which is a PD-1 immune checkpoint inhibitor, becomes the first of a carefully wa...